Open Orphan - Business update
ORPH
Tue, 04 Feb 2020, 09:00am GMT
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug-focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
https://www.openorphan.com
Cathal Friel, Executive Chairman of Open Orphan, provides an update on developments at the company following the successful fundraising, and also introduces Professor John Oxford - a leading expert in the field of virology and an original founder of hVIVO - who will be working with the company as a consultant.